Electra Therapeutics

About:

Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.

Website: https://electra-therapeutics.com/

Top Investors: OrbiMed, RA Capital Management, Cormorant Asset Management, New Leaf Venture Partners, Cowen Healthcare Investments

Description:

Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Electra currently has one program in clinical development and two additional preclinical programs. The company’s lead product candidate, ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells, and depletes pathological immune cells. ELA026 is in clinical development for secondary hemophagocytic lymphohistiocytosis (sHLH), a life-threatening hyperinflammatory condition for which there is no approved treatment.